CompletedNot Applicable

Effect of Ultrasound-enhanced Bee Venom on Selected Post Inguinal Hernioplasty Complications

Egypt66 participantsStarted 2021-03-02

Plain-language summary

Objectives: Bee venom phonophoresis has been suggested as a noninvasive treatment for a number of inflammatory conditions and to reduce postoperative pain. The aim of this study was to evaluate the effect of bee venom phonophoresis on selected acupuncture points for the treatment of pain, inflammation, and mobility of the hip following inguinal hernioplasty. HYPOTHESES: It will be hypothesized that: It was hypothesized that Bee venom phonophoresis has no or limited effect in improvement of post inguinal hernioplasty complication. RESEARCH QUESTION: Does Bee venom phonophoresis an effect in improvement of post inguinal hernioplasty complication?

Who can participate

Age range

28 Years – 50 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients ranged in age from 28 to 50 years old. * They had not previously undertaken another physical therapy modality for pain * Non-smokers * Under their own prescribed medications described by their physicians. Exclusion Criteria: Patients were excluded if they: * had non-mesh inguinal hernioplasty. * suffered from open or infected wounds. * had any systemic diseases that may interfere with the study's objectives such as using chemo or radiotherapy. * had allergy to bee venom. * had associated disorders, such as immunodeficiency, HIV, diabetes, or anemia.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Serum C-reactive protein (CRP)

Timeframe: change in CRP calculated at post-3 weeks of treatment minus baseline.

Manual Goniometer

Timeframe: change in ranges of motion calculated at post-3 weeks of treatment minus baseline.

The visual analogue scale (VAS)

Timeframe: change in VAS calculated at post-3 weeks of treatment minus baseline.

Trial details

NCT IDNCT05286463

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-02-05

View on ClinicalTrials.gov More Complications; C, Intestinal (Internal) trials